Roswell Biotechnologies Stock
Revolutionizing Reading DNA through Molecular Electronics
Sign up today and learn more about Roswell Biotechnologies Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Roswell Biotechnologies Stock
Roswell Biotechnologies is a molecular electronics company transforming DNA sequencing with their latest platform, designed to deliver the disruptive performance required for future biomedical and industrial applications. The platform technology, ENDSeq™ (Electronic Nano-Device Sequencing), deploys single molecule sensor nanotechnology in a scalable semiconductor chip format, to deliver a dramatic reduction in the cost of genome-sequencing with unprecedented speed, accuracy and simplicity. Roswell is focused on delivering the molecular electronics chip and system that provides a $100, 1-hour whole human genome for use in precision medicine.
Funding History
December 2017 | $5.0M |
---|---|
January 2019 | $32.0M |
Press
globenewswire - Jan, 27 2024
Global Whole Genome and Exome Sequencing Industry ...globenewswire - Dec, 28 2023
Global Genetic Testing Market Research Report 2023-2027 ...genomeweb - Jun, 10 2022
Roswell Biotechnologies Teams up With UCB on Use of Molecular Electronics Tech for Drug Developmentprnewswire - Jan, 24 2022
Roswell Biotechnologies Demonstrates First Scalable Molecular Electronics Chip in Peer-Review Paperbiospace - Nov, 15 2021
Roswell Biotechnologies Unveils First Molecular Electronics Chip to Digitize Biology